-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Protagonist Therapeutics, Raises Price Target to $118

Benzinga·02/02/2026 21:24:29
Listen to the news
Jefferies analyst Roger Song maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $95 to $118.